The North America Cold Plasma Market was valued at $912.2 Million in 2024 and projected to reach to $1499.9 Million by 2029, representing a compound annual growth rate of 10.5%. North America's cold plasma market is positioned for sustained expansion through 2029, driven by technological advancements and increasing clinical validation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America's cold plasma market is valued at $912.2 million in 2024, with a robust CAGR of 10.5%, projected to reach $1,499.9 million by 2029, outpacing global growth expectations.
North America benefits from world-class healthcare systems, significant R&D investments, and early adoption of cutting-edge medical technologies, positioning the region as a leader in cold plasma innovation.
Rising demand for minimally invasive surgical and therapeutic procedures across North American healthcare facilities is driving cold plasma adoption in wound healing, sterilization, and dermatological applications.
Increased funding in research and development by North American healthcare institutions and biotech companies is accelerating clinical applications and regulatory approvals for cold plasma technologies.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MEDICAL INDUSTRY (Industry) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11% from 2024 to 2029 |
| Largest Segment | ATMOSPHERIC COLD PLASMA (Regime) |
| Market Size Base Year (Billions) | ~USD 2.14 (2024) |
| Revenue Forecast (Billions) | ~USD 3.6 (2029) |
| Segments Covered | Industry, Application, Regime |
3 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| US | USD 509.51 Million |
| Canada | USD 40.99 Million |
The North America cold plasma market was valued at $912.2 million in 2024 and is expected to reach $1,499.9 million by 2029.
North America's cold plasma market is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2029.
North America's growth is driven by advanced healthcare infrastructure, favorable reimbursement policies, increasing R&D investment, and rising demand for minimally invasive surgical solutions.
North America's hospitals and outpatient surgical centers are actively integrating cold plasma systems into their clinical workflows and treatment protocols.
North America's cold plasma market includes established medical device manufacturers and emerging innovators focused on expanding therapeutic applications and improving treatment outcomes.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Plasma Protein Therapeutic Association (PPTA), International Diabetes Federation (IDF),European Textile Services Association (ETSA), National Council of Textile Organizations (NCTO), Semiconductor Industry Association (SIA), International Journal of Plastic and Polymer Technology (IJPPT), International Journal of Engineering Research & Technology (IJERT and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global cold plasma market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the cold plasma market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global cold plasma market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global cold plasma market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global cold plasma market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and excited & ground-state molecules. It is an innovative and convenient alternative to traditional and conventional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.
Full forecast, segment splits, and company analysis for all Cold Plasma Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report